Back
ghmpn | 20801

MPN Panel Mutations

Keywords:
2AF1
ASXL1
CALR
CBL
CEBPA
CSF3R
DNMT3A
ET
EZH2
Essential thrombocythaemia
IDH1
IDH2
JAK2
KIT
MPL
MPN
Myeloproliferative neoplasms NGS
NRAS
PMF
PV
Polycythaemia vera
RUNX1
SETBP1
SF3B1
SH2B3
SRSF2
TET2
TP53
ZRSR2
primary myelofibrosis

Status

Hint
ASXL1, CALR, CBL, CEBPA, CSF3R, DNMT3A, EZH2, IDH1, IDH2, JAK2, KIT, MPL, NRAS, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, TET2, TP53, U2AF1, ZRSR2 | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).
Min. volume 4 mL
Stability
Stability
2 days / 18-25°C
Duration 1 week
Frequency 1 x per week
Method Next Generation Sequencing

Price/Rate

Price
Price
CHF 2’554.90
Rate
Rate
2'554.90 TP